Australia has one of the highest rates
of allergic disease in the world. We know that children are born with a
relatively poor skin barrier in early life. What we believe is happening is
this poor skin barrier is allowing allergens through the skin which leads to
sensitisation, and then eventually allergic disease. We’re investigating a form of intervention that aims to prevent the
development of eczema and food allergy. What we’re using is an intervention
called Epiceram, it’s a barrier cream that specifically aims to build up skin
barrier function. So in this round of the study we’ll be recruiting 760 children from around Melbourne. We need them to have a family history of allergic disease, and the baby needs to be less than three weeks of age.